CNS Pharmaceuticals Inc. (CNSP)
Market Open
15 Jun, 17:16
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
4. 98
+0.09
+1.8425%
$
2.81M Market Cap
- P/E Ratio
- Div Yield
4,204 Volume
0 Eps
$ 4.89
Previous Close Investors:
Want to track CNSP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript
CNS Pharmaceuticals, Inc. ( CNSP ) Shareholder/Analyst Call November 17, 2025 12:00 PM EST Company Participants John Climaco - CEO, President & Director Christopher Downs - Chief Financial Officer Presentation John Climaco CEO, President & Director Welcome, everyone. The Annual Meeting of the Stockholders of CNS Pharmaceuticals, Inc. is hereby convened and called to order.
Seekingalpha | 6 months ago
Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today?
CNS Pharmaceuticals (NASDAQ: CNSP ) stock is heading lower on Tuesday after the clinical-pharmaceutical company announced an expansion to its pipeline. CNS Pharmaceuticals has acquired an exclusive license and the intellectual property rights to TPI 287.
Investorplace | 1 year ago
